Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Vicente E TorresArlene B ChapmanOlivier DevuystRon T GansevoortVicente E TorresJennifer LeeMolly E HokeAlvin EstiloOlga SergeyevaPublished in: Clinical journal of the American Society of Nephrology : CJASN (2020)
Open Label Extension of TEMPO 3:4, NCT02251275.